Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HYUN K KANG

Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery

NPI
1184046195
CMS profile
98612
Location
GARDEN GROVE, CA

General Payments · PY2018–2024

$19,118.81

  • Reported across 82 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$539.10

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $539.10 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $156.58 6
Linvatec Corporation $151.07 1
ABBVIE INC. $112.89 1
Paratek Pharmaceuticals, Inc. $61.12 3
Bioventus LLC $20.31 1
Abbott Laboratories $19.15 1
Averitas Pharma Inc. $17.98 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $448.53 27
PY2019 $271.79 6
PY2020 $524.43 8
PY2021 $94.56 1
PY2022 $17,033.65 16
PY2023 $206.75 10
PY2024 $539.10 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $19.15 09/26/2024 Food and Beverage Undisputed 01/23/2026 1124886026 CMS
ABBVIE INC. $112.89 04/03/2024 Food and Beverage Undisputed 01/23/2026 1104027483 CMS
Amgen Inc. $25.33 04/02/2024 Food and Beverage Undisputed 01/23/2026 1111613751 CMS
Amgen Inc. $6.33 06/04/2024 Food and Beverage Undisputed 01/23/2026 1111613753 CMS
Amgen Inc. $69.88 06/05/2024 Food and Beverage Undisputed 01/23/2026 1111613755 CMS
Amgen Inc. $9.43 11/12/2024 Food and Beverage Undisputed 01/23/2026 1111613757 CMS
Amgen Inc. $34.01 12/10/2024 Food and Beverage Undisputed 01/23/2026 1111613759 CMS
Amgen Inc. $11.60 12/17/2024 Food and Beverage Undisputed 01/23/2026 1111613761 CMS
Averitas Pharma Inc. $17.98 04/09/2024 Food and Beverage Undisputed 01/23/2026 1133431481 CMS
Bioventus LLC $20.31 03/28/2024 Food and Beverage Undisputed 01/23/2026 1137442876 CMS
Linvatec Corporation $151.07 02/07/2024 Food and Beverage Undisputed 01/23/2026 1147086318 CMS
Paratek Pharmaceuticals, Inc. $22.27 02/27/2024 Food and Beverage Undisputed 01/23/2026 1113905589 CMS
Paratek Pharmaceuticals, Inc. $23.65 03/26/2024 Food and Beverage Undisputed 01/23/2026 1113905591 CMS
Paratek Pharmaceuticals, Inc. $15.20 06/11/2024 Food and Beverage Undisputed 01/23/2026 1113905593 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.